Skip Nav Destination
Issues
1 June 2002
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Review
The Biology Behind
The Cooperative Group Bulletin Board
Targeted Delivery in Primary and Metastatic Brain Tumors: Summary Report of the Seventh Annual Meeting of the Blood-Brain Barrier Disruption Consortium1
Nancy D. Doolittle; Lauren E. Abrey; Nicolay Ferrari; Walter A. Hall; Edward R. Laws; Roger E. McLendon; Leslie L. Muldoon; David Peereboom; Darryl R. Peterson; C. Patrick Reynolds; Peter Senter; Edward A. Neuwelt
Advances in Brief
Experimental Therapeutics, Preclinical Pharmacology
Molecular Oncology, Markers, Clinical Correlates
Regular Articles
Clinical Trials
A Phase I Study with an Anti-CD30 Ricin A-Chain Immunotoxin (Ki-4.dgA) in Patients with Refractory CD30+ Hodgkin’s and Non-Hodgkin’s Lymphoma1
Roland Schnell; Oliver Staak; Peter Borchmann; Christine Schwartz; Bärbel Matthey; Hinrich Hansen; John Schindler; Victor Ghetie; Ellen S. Vitetta; Volker Diehl; Andreas Engert
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Reverse Transcription-Polymerase Chain Reaction Detection of Prostate-specific Antigen, Prostate-specific Membrane Antigen, and Prostate Stem Cell Antigen in One Milliliter of Peripheral Blood: Value for the Staging of Prostate Cancer
Noboru Hara; Takashi Kasahara; Takashi Kawasaki; Vladimir Bilim; Kenji Obara; Kota Takahashi; Yoshihiko Tomita
Expression of Cell-Cycle-regulated Proteins pRb2/p130, p107, p27kip1, p53, mdm-2, and Ki-67 (MIB-1) in Prostatic Gland Adenocarcinoma1
Pier Paolo Claudio; Alessandra Zamparelli; Fernando U. Garcia; Luigi Claudio; Giuseppe Ammirati; Antonio Farina; Alessandro Bovicelli; Giuseppe Russo; Giovan Giacomo Giordano; David E. McGinnis; Antonio Giordano; Gaetano Cardi
Changes in Microvessel Density As Assessed by CD34 Antibodies after Primary Chemotherapy in Human Breast Cancer1
Alberto Bottini; Alfredo Berruti; Alessandra Bersiga; Maria Pia Brizzi; Giovanni Allevi; Giovanna Bolsi; Sergio Aguggini; Antonio Brunelli; Enrico Betri; Daniele Generali; Lorena Scaratti; Giovanni Bertoli; Palmiro Alquati; Luigi Dogliotti
Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer
Monika Schindl; Sebastian F. Schoppmann; Hellmut Samonigg; Hubert Hausmaninger; Werner Kwasny; Michael Gnant; Raimund Jakesz; Ernst Kubista; Peter Birner; Georg Oberhuber; the Austrian Breast Colorectal Cancer Study Group
Experimental Therapeutics, Preclinical Pharmacology
Synthetic Matrix Metalloproteinase Inhibitors Inhibit Growth of Established Breast Cancer Osteolytic Lesions and Prolong Survival in Mice
Bent Winding; Róisín NicAmhlaoibh; Henriette Misander; Pernille Høegh-Andersen; Thomas Levin Andersen; Claus Holst-Hansen; Anne-Marie Heegaard; Niels Tækker Foged; Nils Brünner; Jean-Marie Delaissé
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.